CASI Pharmaceuticals, Inc. (CASIF): Shares Outstanding
20.56M
As of 2025-12-31
+15.2%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 20.56M | +32.7% | 2026-05-15, Balance as of period end |
| 2024-12-31 | 15.49M | +15.8% | 2026-05-15, Balance as of period end |
| 2023-12-31 | 13.38M | -0.6% | 2025-03-31, Balance as of period end |
| 2022-12-31 | 13.46M | -3.7% | 2024-03-28, Balance as of period end |
| 2021-12-31 | 13.98M | n/a | 2023-04-26, Balance as of period end |